But in the ISSYS
application, a void might be very tiny and still result in a leak.
is a leader in advanced MEMS technologies for medical devices, microfluidic and scientific analytical sensing applications.
is currently developing small methanol concentration sensors, targeting the active direct methanol fuel cell (DMFC) market.
The success spawned the creation of the ISSYS
subsidiary, NanoGetters, which Sparks now heads.
noted that it is both developing its own products and working with Japan's Kyoto Electronics Manufacturing Company (KEM) on another version of the device.
To maximize the impenetrability and durability of the vacuum sealing, both glass bonding and frit sealing are employed at ISSYS
is a leader in advanced micromachining technologies for medical devices, microfluidic and scientific analytical sensing applications used in the development of drug infusion pumps and wireless, implantable sensing systems.
MEMS is an indispensable technology that fills this recent need, so it was of prime importance for us to tie up with ISSYS
in order to realize our global strategy.
Nader Najafi, President and CEO of ISSYS
stated that, "We greatly appreciate the support from the State of Michigan, Michigan Economy Development Corporation (MEDC) and the MTTC program.
Douglas Sparks, Executive VP of ISSYS
stated that, "The system and novel method will greatly improve the safety of drug delivery.
The award ("Commercializing a Life-Saving Drug Infusion System") is dedicated to commercializing drug infusion products developed at ISSYS
This patent describes a new method of forming micromachined tubes used by ISSYS
to produce drug infusion devices, microneedles, flow and fuel cell sensors and density meters.